Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.

Advances in experimental medicine and biology - 1 Jan 2017

Steiner Johann, Guest Paul C, Martins-de-Souza Daniel

Abstract excerpt

For major psychiatric disorders such as schizophrenia, there have been shortcomings in the translation of scientific findings into new treatments and this has led to diminished interest for large pharmaceutical companies. This chapter describes how incorporation of proteomic approaches into the clinical pipeline can lead to identification and implementation of biomarker tests for improved patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Forecasting
Share to Hormones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to International Classification of Diseases

Share to Lab-On-A-Chip Devices

Share to Neurosecretory Systems

Share to Proteomics

Source

Identifiers

PMID: 28353222
DOI: 10.1007/978-3-319-52479-5_1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.PMID 28353222Read ↗

Application and integration of bioinformatic strategies towards central and peripheral proteomic profiling for diagnosis and drug discovery in schizophreniaSemantic proximity Read ↗

Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Proteome analysis of schizophrenia brain tissueSemantic proximity Read ↗

Cerebrospinal fluid proteomics reveals synaptic and immune dysregulation in treatment-resistant schizophreniaSemantic proximity Read ↗

Proteomics Research in SchizophreniaSemantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsSemantic proximity Read ↗

Revealing potential drug targets in schizophrenia through proteome-wide Mendelian randomization genetic insights.Semantic proximity Read ↗

The difference in serum proteomes in schizophrenia and bipolar disorderSemantic proximity Read ↗

A roadmap to disentangle the molecular etiology of schizophrenia.Semantic proximity Read ↗

The Multiomics Landscape of Plasma Exosomes in First-Episode Drug-Naïve of SchizophreniaSemantic proximity Read ↗

Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune PathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.